We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward
Industry Insight

We recently spoke to GenScript’s VP of Marketing, Eric Wang, to learn more about the company’s mission to “make people and nature healthier through biotechnology”. Eric discusses the key phases of antibody therapeutic discovery and development, GenScript’s role in advancing drug discovery research, and tells us about the company’s recently launched custom rabbit monoclonal antibody service.

Read More

Genomic Profiling in Cancer: Matching Patients to Precision Trials, Guiding Patients to the Right Treatment
Industry Insight

We recently spoke to Gaurav Singal, Vice President of Data Strategy and Product Development at Foundation Medicine, to learn more about how their SmartTrialsTM technology platform has enabled patients to be rapidly matched to precision trials, based on their unique tumor biomarkers.

Read More

Harnessing Stem Cells for Blood Vessel Regeneration
Industry Insight

Vascugen recently announced that it had licensed stem cell technology for blood vessel regeneration at IU School of Medicine, which could lead to new treatment options for patients suffering from Peripheral Artery Disease and Critical Limb Ischemia. We caught up with Carter Cliff, CEO, Vascugen to learn more about the technology and the science behind it.

Read More

A New Generation of Flow Cytometers Advances Multiomics
Industry Insight

Flow cytometry allows the analysis of physical and biochemical features of cells. Advances in machine that can characterize and sort cells will allow researchers to look deeper than ever before into the proteome and transcriptome. We talk with Bob Balderas, VP Market Development at BD on how the cutting-edge machines like the FACSymphony S6 cell sorter incorporate new technology and advance multiomics research.

Read More

Streamlining Monoclonal Antibody Purification for Therapeutic Candidate Screening
Industry Insight

To develop the best therapeutic mAb for treatment of a disease, hundreds of clones must be screened in downstream assays characterizing specificity, affinity, and binding kinetics. This article highlights ways to increase the throughput of purifying mAbs.

Read More

Biopharmaceutical Manufacturing: Creating a Robust and Productive Process
Industry Insight

We recently spoke to Alice S. Chuck, Ph.D. Manufacturing Sciences & Technology Team Leader at Samsung BioLogics to learn more about the company and the completion of their newest facility, 'Songdo Plant No.3'. Alice discusses the key stages of biomanufacturing and highlights the importance of regulatory compliance.

Read More

Optimizing Data Visualization and Analysis for Biologics Discovery
Industry Insight

This blog discusses the challenges associated with harnessing large data sets and the implications that could arise from the inability to sufficiently access, share and analyze scientific data in terms of biopharmaceutical and small molecule discovery.

Read More

Targeting Your Best Clinical Candidate With Self Guided Data Discovery and Analysis
Industry Insight

We spoke with Daniel Weaver, Senior Product Manager for PerkinElmer, to find out more about their new platform PerkinElmer Signals™ Lead Discovery (SLD).

Read More

Handling Potent Active Pharmaceutical Ingredients
Industry Insight

APIs are a critical component of the pharmaceutical supply chain, and it is important that biopharmaceutical companies integrate potent API management and handling concepts in to their daily operations. We spoke to Justin Mason-Home, to learn more about the importance of applying robust occupational health and safety processes to the drug discovery and development pipeline.

Read More

Revolutionizing the World of Pipetting
Industry Insight

Necessity is the mother of invention, and nowhere is this more clearly demonstrated than in the laboratory. We caught up with Alex Studer, VP of Marketing and Innovation at INTEGRA Biosciences, to discuss the company’s aim to transform the world of pipetting.

Read More

 
Advertisement